Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Peng Liu [1 ]
Xu Zhu [1 ]
Jie Li [2 ]
Ming Lu [2 ]
Jiahua Leng [3 ]
Ying Li [4 ]
Jiangyuan Yu [5 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Interventional Therapy,Peking University Cancer Hospital & Institute
[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastroenterological Oncology,Peking University Cancer Hospital & Institute
[3] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Surgery Unit Ⅲ,Peking University Cancer Hospital & Institute
[4] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital & Institute
[5] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Nuclear Medicine,Peking University Cancer Hospital & Institute
基金
中国国家自然科学基金;
关键词
Gastroenteropancreatic neuroendocrine tumors; hepatic metastasis; angiography; interventional treatment; retrospective analysis;
D O I
暂无
中图分类号
R735 [消化系肿瘤];
学科分类号
摘要
Objective: To analyze the angiography appearance of liver metastases from gastroenteropancreatic neuroendocrine tumors(GEP-NETs),and evaluate the clinical efficacy and prognostic factors of interventional treatment for hepatic metastases.Methods: Fifty GEP-NETs patients with hepatic metastases were treated from January 2012 to December 2016,and received transarterial embolization(TAE) in the hepatic tumor or hepatic arterial infusion chemotherapy(HAIC).All patients received 179 times of the intervention therapy in total.Results: Blood supplies were identified in the 50 cases with angiography,which showed that 35 cases had abundant vessels,while 15 cases had poor blood supply.Twenty-two cases were found either collateral blood supply,or portal vein invasion or arterial-portal vein fistula.The best curative efficacy was complete remission(CR)in 4 cases,partial remission(PR) in 28 cases and stable disease(SD) in 18 cases during the process of treatment.The angiography(P=0.047) and the frequency of intervention(P=0.037) showed significantly statistical difference with Kaplan-Meier analysis.The Cox analysis showed that more than 3 times of interventional therapy was an independent prognostic factor.Conclusions: Interventional treatment is safe and effective for GEP-NETs,and is beneficial to patients with main hepatic metastases after endocrine therapy.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 50 条
  • [21] Gastroenteropancreatic Neuroendocrine Tumors - A Nine-Year Retrospective Analysis of Own Material
    Kaliszewski, Krzysztof
    Bednarz, Wiktor
    Lukienczuk, Tadeusz
    Sutkowski, Krzysztof
    Wojtczak, Beata
    Balcerzak, Waldemar
    Domoslawski, Pawel
    Rzeszutko, Marta
    Kaliszewska, Magdalena
    Dawiskiba, Janusz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 18 (06): : 589 - 594
  • [22] Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
    Cives, Mauro
    Pelle', Eleonora
    Strosberg, Jonathan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 13
  • [23] Systemic therapy in the treatment of gastroenteropancreatic neuroendocrine tumors
    Deptala, Andrzej
    Asendrych, Alicja
    Omyla-Staszewska, Joanna
    Rzymkowska, Joanna
    PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (01): : 10 - 15
  • [24] Gastroenteropancreatic Neuroendocrine Tumors: Hormonal Treatment Updates
    Khagi, Simon
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 135 - 137
  • [25] Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
    Beyens, Matthias
    Vandamme, Timon
    Peeters, Marc
    Van Camp, Guy
    Op de Beeck, Ken
    ENDOCRINE-RELATED CANCER, 2019, 26 (03) : R109 - R130
  • [26] Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)
    Dhingra, Rohit
    Tse, Julie Y.
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2018, 19 (05): : 258 - 260
  • [27] Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Frequency, Treatment and Prognosis
    Madani, A.
    Thomassen, I
    Van Gestel, Y.
    Van der Bilt, J.
    Haak, H.
    De Hingh, I
    Lemmens, V
    NEUROENDOCRINOLOGY, 2016, 103 : 32 - 32
  • [28] Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis
    A. Laffi
    F. Spada
    V. Bagnardi
    S. Frassoni
    E. Pisa
    M. Rubino
    M. Barberis
    N. Fazio
    Journal of Endocrinological Investigation, 2022, 45 : 317 - 325
  • [29] Risk Factors Associated with the Development of Metastases in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis
    Kohno, Shuzo
    Ikegami, Masahiro
    Ikegami, Toru
    Aoki, Hiroaki
    Ogawa, Masaichi
    Yano, Fumiaki
    Eto, Ken
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [30] Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis
    Laffi, A.
    Spada, F.
    Bagnardi, V
    Frassoni, S.
    Pisa, E.
    Rubino, M.
    Barberis, M.
    Fazio, N.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (02) : 317 - 325